GH Research Shares Rise After Reports of Eli Lilly Talks to Buy Atai
GH Research (NASDAQ:GHRS) jumped about 12% in premarket trading after reports that Eli Lilly is in discussions to acquire Atai Life Sciences (NASDAQ:ATAI), whose stock surged as much as 53% premarket. RBC Capital Markets analyst Brian Abrahams identified GH Research as the most direct comparable to Atai, citing near-identical mechanisms and target …